These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 19449750

  • 1. [Hypolipidemic drugs and diabetes mellitus].
    Bláha V, Mistrík E.
    Vnitr Lek; 2009 Apr; 55(4):357-62. PubMed ID: 19449750
    [Abstract] [Full Text] [Related]

  • 2. Lipid lowering in diabetes mellitus.
    Betteridge DJ.
    Curr Opin Lipidol; 2008 Dec; 19(6):579-84. PubMed ID: 18957880
    [Abstract] [Full Text] [Related]

  • 3. [Dyslipidemia in diabetes mellitus].
    Niemeijer-Kanters SD, Banga JD, Erkelens DW.
    Ned Tijdschr Geneeskd; 2001 Apr 21; 145(16):769-74. PubMed ID: 11346913
    [Abstract] [Full Text] [Related]

  • 4. Diabetic dyslipidemia: extending the target beyond LDL cholesterol.
    Nicholls SJ, Lundman P, Tardif JC.
    Eur J Cardiovasc Prev Rehabil; 2010 May 21; 17 Suppl 1():S20-4. PubMed ID: 20489416
    [Abstract] [Full Text] [Related]

  • 5. [Favorable effects of decreasing lipids in patients with diabetes mellitus].
    Gouni-Berthold I, Krone W.
    Dtsch Med Wochenschr; 2006 Dec 21; 131 Suppl 8():S252-4. PubMed ID: 17139581
    [Abstract] [Full Text] [Related]

  • 6. [Disorders of lipid metabolism in 3 patients with diabetes mellitus type 2].
    Wolffenbuttel BH, Huijberts MS.
    Ned Tijdschr Geneeskd; 2001 Apr 21; 145(16):761-5. PubMed ID: 11346911
    [Abstract] [Full Text] [Related]

  • 7. Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering.
    Jones PH.
    Am J Cardiol; 2008 Dec 22; 102(12A):41L-47L. PubMed ID: 19084089
    [Abstract] [Full Text] [Related]

  • 8. Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease.
    Staels B, Maes M, Zambon A.
    Nat Clin Pract Cardiovasc Med; 2008 Sep 22; 5(9):542-53. PubMed ID: 18628776
    [Abstract] [Full Text] [Related]

  • 9. Lipid-lowering therapy in patients with type 2 diabetes: the case for early intervention.
    Steinmetz A.
    Diabetes Metab Res Rev; 2008 Sep 22; 24(4):286-93. PubMed ID: 18273835
    [Abstract] [Full Text] [Related]

  • 10. Effects of pioglitazone on lipid and lipoprotein metabolism.
    Betteridge DJ.
    Diabetes Obes Metab; 2007 Sep 22; 9(5):640-7. PubMed ID: 17697057
    [Abstract] [Full Text] [Related]

  • 11. [Diabetic dyslipoproteinemia: beyond LDL].
    Merkel M.
    Dtsch Med Wochenschr; 2009 May 22; 134(20):1067-73. PubMed ID: 19421932
    [Abstract] [Full Text] [Related]

  • 12. Nicotinic acid in the treatment of hyperlipidaemia.
    Drexel H.
    Fundam Clin Pharmacol; 2007 Nov 22; 21 Suppl 2():5-6. PubMed ID: 18001312
    [Abstract] [Full Text] [Related]

  • 13. [Diabetic dyslipidemia: which target levels and treatment options exist for diabetics?].
    Broedl UC, Lehrke M, Parhofer KG.
    MMW Fortschr Med; 2008 Jun 19; 150(25):41-3. PubMed ID: 18705054
    [No Abstract] [Full Text] [Related]

  • 14. Beyond LDL cholesterol: the role of elevated triglycerides and low HDL cholesterol in residual CVD risk remaining after statin therapy.
    Alagona P.
    Am J Manag Care; 2009 Mar 19; 15(3 Suppl):S65-73. PubMed ID: 19355805
    [Abstract] [Full Text] [Related]

  • 15. New strategies in the treatment of dyslipidemia: do we know how?
    Vrablík M, Ceska R.
    Semin Vasc Med; 2004 Aug 19; 4(3):305-10. PubMed ID: 15630630
    [Abstract] [Full Text] [Related]

  • 16. Managing dyslipidemia in adults with diabetes.
    Haffner SM.
    Manag Care; 2003 Sep 19; 12(9 Suppl):10-5. PubMed ID: 14535130
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of high-risk older persons with lipid-lowering drug therapy.
    Aronow WS.
    Am J Ther; 2008 Sep 19; 15(2):102-7. PubMed ID: 18356628
    [Abstract] [Full Text] [Related]

  • 18. The future of lipid-lowering therapy: the big picture.
    Kastelein JJ.
    Neth J Med; 2003 May 19; 61(5 Suppl):35-9. PubMed ID: 12918548
    [Abstract] [Full Text] [Related]

  • 19. Rationale for new American Diabetes Association Guidelines: are national cholesterol education program goals adequate for the patient with diabetes mellitus?
    Haffner S.
    Am J Cardiol; 2005 Aug 22; 96(4A):33E-36E. PubMed ID: 16098841
    [Abstract] [Full Text] [Related]

  • 20. Do people with diabetes need statins?
    White JR.
    Diabetes Educ; 2008 Aug 22; 34(4):664-73. PubMed ID: 18669808
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.